Inventor · disambiguated record
Laurent Gauthier
Also filed as: GAUTHIER LAURENT
59 granted patents·37 pending applications·476 citations·filing 1997–2025
98Inventor score
Top patents by PatentIndex Score
96 records- 0197US9717803B2Enzymatic conjugation of polypeptidesINNATE PHARMA·Filed 2012·Granted Aug 1, 2017·29 cites·40 claims
- 0296US11958907B2CD73 blockadeINNATE PHARMA·Filed 2020·Granted Apr 16, 2024·4 cites·21 claims
- 0396US10675359B2Enzymatic conjugation of antibodiesINNATE PHARMA·Filed 2017·Granted Jun 9, 2020·11 cites·24 claims
- 0496US9764038B2Enzymatic conjugation of antibodiesINNATE PHARMA·Filed 2012·Granted Sep 19, 2017·38 cites·13 claims
- 0595US11891444B2Variable regions for NKp46 binding proteinsINNATE PHARMA·Filed 2021·Granted Feb 6, 2024·3 cites·15 claims
- 0695US8119775B2Human anti-KIR antibodiesMORETTA ALESSANDRO·Filed 2008·Granted Feb 21, 2012·68 cites·20 claims
- 0794US11267897B2Multispecific NK engager proteinINNATE PHARMA·Filed 2018·Granted Mar 8, 2022·8 cites·19 claims
- 0894US10577419B2KIR3DL2 binding agentsINNATE PHARMA·Filed 2015·Granted Mar 3, 2020·15 cites·10 claims
- 0994US10434180B2Enzymatic conjugation of polypeptidesINNATE PHARMA·Filed 2016·Granted Oct 8, 2019·20 cites·13 claims
- 1094US9427478B2Enzymatic conjugation of polypeptidesINNATE PHARMA·Filed 2014·Granted Aug 30, 2016·30 cites·21 claims
- 1193US10113003B2Multispecific NK engager proteinsINNATE PHARMA·Filed 2016·Granted Oct 30, 2018·15 cites·28 claims
- 1292US9197403B2Calibration arrangement for frequency synthesizersGAUTHIER LAURENT·Filed 2012·Granted Nov 24, 2015·15 cites·17 claims
- 1391US11066470B2Humanized antibodies with increased stabilityINNATE PHARMA·Filed 2019·Granted Jul 20, 2021·3 cites·13 claims
- 1491US8981065B2Human anti-KIR antibodiesNOVO NORDISK AS —NOVO ALLE·Filed 2013·Granted Mar 17, 2015·25 cites·18 claims
- 1590US10280222B2Humanized antibodies with increased stabilityINNATE PHARMA·Filed 2015·Granted May 7, 2019·8 cites·7 claims
- 1689US11692039B2Multifunctional natural killer (NK) cell engagers binding to NKp46 and CD123INNATE PHARMA·Filed 2021·Granted Jul 4, 2023·2 cites·22 claims
- 1789US11377503B2Antibodies that bind human CD39 and inhibit ATPase activity of a soluble extracellular domain human CD39 polypeptideINNATE PHARMA·Filed 2019·Granted Jul 5, 2022·3 cites·13 claims
- 1889US10766966B2CD73 blockadeINNATE PHARMA·Filed 2015·Granted Sep 8, 2020·5 cites·12 claims
- 1989US10246510B2KIR3DL2 binding agentsINNATE PHARMA·Filed 2013·Granted Apr 2, 2019·9 cites·20 claims
- 2089US8637258B2Compositions and methods for regulating NK cell activityPADKJAER SOREN BERG·Filed 2010·Granted Jan 28, 2014·23 cites·14 claims
- 2189US8273481B2Process for preparing electroactive insertion compounds and electrode materials obtained therefromGAUTHIER LAURENT·Filed 2011·Granted Sep 25, 2012·4 cites·33 claims
- 2288US11858990B2KIR3DL2 binding agentsINNATE PHARMA·Filed 2020·Granted Jan 2, 2024·2 cites·7 claims
- 2388US11001629B2Variable regions for NKp46 binding proteinsINNATE PHARMA·Filed 2016·Granted May 11, 2021·7 cites·6 claims
- 2488US9828427B2Anti-KIR3D antibodiesINNATE PHARMA·Filed 2015·Granted Nov 28, 2017·9 cites·7 claims
- 2588US8048565B2Process for preparing electroactive insertion compounds and electrode materials obtained therefromUNIV MONTREAL·Filed 2010·Granted Nov 1, 2011·4 cites·41 claims
- 2686US12195555B2Natural killer (NK) cell engagers binding to NKp46 and BCMA variants with Fc-engineeringSANOFI SA·Filed 2023·Granted Jan 14, 2025·1 cites·33 claims
- 2786US10519234B2NKp46 binding proteinsINNATE PHARMA·Filed 2015·Granted Dec 31, 2019·6 cites·12 claims
- 2885US11208480B2Multispecific antigen binding proteinsINNATE PHARMA·Filed 2015·Granted Dec 28, 2021·3 cites·8 claims
- 2984US7034899B2Radio command deviceSOMFY SAS·Filed 2002·Granted Apr 25, 2006·28 cites·21 claims
- 3083US11130817B2CD73 blocking agentsINNATE PHARMA·Filed 2016·Granted Sep 28, 2021·3 cites·5 claims
- 3183US9388246B2TLR3 binding agentsGAUTHIER LAURENT·Filed 2011·Granted Jul 12, 2016·9 cites·55 claims
- 3281US7534408B2Process for preparing electroactive insertion compounds and electrode materials obtained therefromUNIV MONTREAL·Filed 2004·Granted May 19, 2009·12 cites·41 claims
- 3380US11845795B2NKp46 binding proteinsINNATE PHARMA·Filed 2019·Granted Dec 19, 2023·1 cites·12 claims
- 3480US9181341B2Anti-KIR3D antibodiesANFOSSI NICOLAS·Filed 2010·Granted Nov 10, 2015·9 cites·11 claims
- 3580US2024124579A1Kir3dl2 binding agentsINNATE PHARMA·Filed 2023·Application pending·0 cites
- 3679US12202907B2Nucleic acids encoding and methods of producing proteins comprising antibody chainsINNATE PHARMA·Filed 2022·Granted Jan 21, 2025·0 cites·36 claims
- 3779US2024174748A1Variable regions for nkp46 binding proteinsINNATE PHARMA·Filed 2024·Application pending·0 cites
- 3878US11623954B2Siglec-9-neutralizing antibodiesINNATE PHARMA·Filed 2018·Granted Apr 11, 2023·1 cites·12 claims
- 3978US11377492B2NKp46 binding agentsINNATE PHARMA·Filed 2018·Granted Jul 5, 2022·1 cites·16 claims
- 4078US10132799B2Screening of conjugated antibodiesINNATE PHARMA·Filed 2013·Granted Nov 20, 2018·3 cites·22 claims
- 4178US8647778B2Process for preparing electroactive insertion compounds and electrode materials obtained therefromGAUTHIER LAURENT·Filed 2012·Granted Feb 11, 2014·1 cites·59 claims
- 4278US2024141042A1MULTISPECIFIC NKp46 BINDING PROTEINSINNATE PHARMA·Filed 2023·Application pending·0 cites
- 4377US12227569B2Humanized antibodies with increased stabilityINNATE PHARMA·Filed 2021·Granted Feb 18, 2025·0 cites·14 claims
- 4477US10577416B2Mica binding agentsINNATE PHARMA SA·Filed 2013·Granted Mar 3, 2020·3 cites·3 claims
- 4575US8897343B2Diversity receiver and transceiverGAUTHIER LAURENT·Filed 2009·Granted Nov 25, 2014·5 cites·14 claims
- 4674US2025197528A1NATURAL KILLER (NK) CELL ENGAGERS BINDING TO NKp46 AND BCMA VARIANTS WITH FC-ENGINEERINGSANOFI SA·Filed 2024·Application pending·0 cites
- 4773US8273541B2Compositions and methods for detecting TLR3CHEMIN KARINE·Filed 2009·Granted Sep 25, 2012·3 cites·14 claims
- 4873US2025230237A1Humanized antibodies with increased stabilityINNATE PHARMA·Filed 2025·Application pending·0 cites
- 4972US11083785B2Siglec-10 antibodiesINNATE PHARMA·Filed 2016·Granted Aug 10, 2021·1 cites·9 claims
- 5072US8133618B2Process for preparing electroactive insertion compounds and electrode materials obtained therefromGAUTHIER LAURENT·Filed 2009·Granted Mar 13, 2012·1 cites·25 claims
Showing the top 50 of 96 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Laurent Gauthier files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →